BDBM281744 (RS)-5-(2-Acryloyl-1,2,3,4-tetrahydroisoquinolin-5-yl)-3,3,6-trifluoro-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide::US10023534, Example 1::US10023534, Example 6

SMILES C=CC(=O)N1CCc2c(cccc2-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC(F)(F)CC4)C1

InChI Key InChIKey=NOGNRPZAKMMEOO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 281744   

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 281744BDBM281744(US10023534, Example 1 | (RS)-5-(2-Acryloyl-1,2,3,4...)
Affinity DataIC50: 0.120nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol Myers Squibb

US Patent
LigandChemical structure of BindingDB Monomer ID 281744BDBM281744(US10023534, Example 1 | (RS)-5-(2-Acryloyl-1,2,3,4...)
Affinity DataIC50: 0.180nMpH: 7.4 T: 2°CAssay Description:To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent